Your browser doesn't support javascript.
loading
Corrigendum to "Asundexian in atrial fibrillation: Can pharmacodynamic data explain the failure?" [Thromb. Res. 236 (2024) 236-239 TR_8963].
Vassart, Julie; Didembourg, Marie; Morimont, Laure; Brisbois, Clotilde; Jamart, Laurent; Lebreton, Aurélien; Mullier, François; Donis, Nathalie; Favresse, Julien; Dogné, Jean-Michel; Douxfils, Jonathan.
Afiliação
  • Vassart J; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Didembourg M; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Morimont L; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium.
  • Brisbois C; QUALIresearch, QUALIblood s.a., Namur, Belgium.
  • Jamart L; Service de cardiologie interventionnelle, Centre Hospitalier Régional Sambre et Meuse (CHRSM), Namur, Belgium.
  • Lebreton A; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.
  • Mullier F; Namur Thrombosis and Hemostasis Center (NTHC), CHU UCL NAMUR, Université catholique de Louvain, Belgium; Institut de Recherche Expérimentale et Clinique (IREC), Pôle Mont, Université catholique de Louvain, Yvoir, Belgium.
  • Donis N; QUALIresearch, QUALIblood s.a., Namur, Belgium.
  • Favresse J; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; Department of Clinical Biology, Clinique Saint-Luc Bouge (SLBO), Bouge, Belgium.
  • Dogné JM; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.
  • Douxfils J; Clinical Pharmacology and Toxicology Research Unit (URPC), Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium; QUALIresearch, QUALIblood s.a., Namur, Belgium; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Fe
Thromb Res ; 240: 109066, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38897048
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article